150 Participants Needed

Prevention Ambassadors for HIV Service Engagement

HP
Overseen ByHeather Pines
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: San Diego State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve HIV testing and service use among people who use drugs (PWUD) in Riverside County, California. It collaborates with a local syringe service program to create "Prevention Ambassadors" who will distribute HIV self-testing kits and share information about local HIV services. The trial will evaluate the effectiveness, acceptability, and practicality of this approach. Individuals who have recently used drugs and are open to discussing HIV testing within their social circles may be well-suited for this trial. As an unphased study, this trial provides participants the chance to contribute to innovative strategies that could enhance community health services.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the Prevention Ambassadors intervention is safe for promoting HIV testing among people who use drugs?

Research has shown that programs like the Prevention Ambassadors can increase HIV testing among people who use drugs. In this program, trained individuals, called ambassadors, share HIV self-testing kits and information with their friends. Although specific safety data for this program is unavailable, similar programs have been safely used in communities.

The Prevention Ambassadors program focuses on education and peer support, which typically pose very low risks for participants. Since this trial does not involve taking any drugs or undergoing medical procedures, it is considered low-risk. Participants mainly engage in social activities and receive information, which are generally easy to handle.12345

Why are researchers excited about this trial?

Researchers are excited about the "Prevention Ambassadors" approach because it offers a fresh strategy for engaging individuals in HIV prevention services. Unlike traditional methods that might rely heavily on clinical settings or medical interventions, this approach leverages community-based ambassadors who can connect with individuals on a more personal and relatable level. This method aims to increase awareness and uptake of prevention services by building trust and fostering open communication within communities. By focusing on peer-led engagement, it has the potential to reach populations that are often underserved or hesitant to access conventional healthcare services.

What evidence suggests that the Prevention Ambassadors intervention is effective for promoting HIV testing and service uptake among people who use drugs?

Research has shown that social networks, such as the Prevention Ambassadors program tested in this trial, can increase HIV testing among people who use drugs. In similar programs, peer leadership has made testing more accessible and relatable. Early efforts with these strategies have shown promise in increasing testing and connecting individuals to services. This approach involves peers distributing HIV self-testing kits and sharing information about local services, which has successfully led to more frequent testing and service use in other areas. People are more likely to take action when encouraged by a trusted community member.16789

Who Is on the Research Team?

HA

Heather A Pines

Principal Investigator

San Diego State University

AR

Angela R Bazzi

Principal Investigator

University of California, San Diego

Are You a Good Fit for This Trial?

This trial is for people who use drugs (PWUD) in Riverside County, California, and are clients of a syringe service program (SSP). It's designed to help them get tested for HIV and connect with HIV services. The specific eligibility criteria aren't provided here, but typically participants would need to meet certain health conditions and agree to the study procedures.

Inclusion Criteria

Index Participant: Reporting drug use (past month)
Index Participant: Having other people who use drugs (PWUD) in one's social network
Peer-Recruit Participant: Reporting drug use (past 3 months)
See 2 more

Exclusion Criteria

Persons who participated in formative study activities related to the development of the PA intervention will not be eligible to participate.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

The Prevention Ambassadors intervention is piloted to promote HIV testing and service uptake among PWUD via peer delivery of HIV self-testing kits

3 months

Follow-up

Participants are monitored for PrEP/ART uptake, HIV testing, and linkage to PrEP/HIV care

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Prevention Ambassadors
Trial Overview The 'Prevention Ambassadors' intervention is being tested. This involves PWUD distributing HIV self-testing kits within their networks alongside information about local HIV services and referrals. The goal is to see if this peer-led approach increases engagement with HIV testing and services.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: SSP Standard of CareExperimental Treatment1 Intervention
Group II: Prevention AmbassadorsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

San Diego State University

Lead Sponsor

Trials
182
Recruited
119,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Dap Health

Collaborator

Trials
1
Recruited
150+

University of California, Riverside

Collaborator

Trials
33
Recruited
14,400+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+

Published Research Related to This Trial

A pilot training program for 70 healthcare providers in South Africa aimed at improving HIV prevention messaging unexpectedly resulted in a decrease in the delivery of prevention messages to HIV positive patients, with the overall message delivery rate dropping from 56% to 50%.
The training did not significantly affect the delivery of prevention messages to HIV negative patients, who maintained a stable message delivery rate of 32%, suggesting that the training's effectiveness may vary based on patient status and that a more focused approach to messaging could be beneficial.
Pre/post evaluation of a pilot prevention with positives training program for healthcare providers in North West Province, Republic of South Africa.Kemp, CG., de Kadt, J., Pillay, E., et al.[2020]
The study found that primary peer-referral engagement (PRE) strategies, particularly social network strategies (SNS), were significantly more effective in identifying people with HIV (PWH) who are undiagnosed or out-of-care, recruiting 256.5 individuals compared to only 15 with sexual partner contact tracing (SPCT).
SNS was able to identify a higher number of undiagnosed (32) and out-of-care (159) PWH compared to SPCT, which only identified 2 undiagnosed and 9 out-of-care individuals, highlighting the importance of social networks in engaging at-risk populations.
Leveraging social networks for identification of people living with HIV who are virally unsuppressed.Cummins, B., Johnson, K., Schneider, JA., et al.[2023]
Altruism and personal connections to HIV were the primary motivations for healthy volunteers participating in early phase prophylactic HIV vaccine trials, highlighting the importance of emotional and social factors in recruitment.
Effective recruitment strategies included targeting organizations related to HIV and health issues, while resource-efficient methods like word of mouth and direct emails proved more successful than group discussions or broader outreach efforts.
Participation in two phase II prophylactic HIV vaccine trials in the UK.Gray, K., Legg, K., Sharp, A., et al.[2016]

Citations

Prevention Ambassadors: Intervention to Promote HIV ...It identifies the role of the intervention that participants receive. Types of arms include experimental arm, active comparator arm, placebo comparator arm, ...
Developing and Pilot Testing Peer Ambassador Stories ...This supplement seeks to bolster the parent K23, by developing and pilot testing a “peer ambassador stories” implementation strategy to enhance the reach of ...
HIV Prevention Ambassador Training Package and ToolkitThe HIV Prevention Ambassador Training Package and Toolkit was created to prepare potential and current PrEP users to be leaders – or “Ambassadors” – in the ...
Intervention to Promote HIV Service Engagement in the ...This project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and service uptake among PWUD.
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40882210/
Protocol for Type I Hybrid Implementation Study (Carolinas ...Social network approaches have led to increased HIV testing uptake. Social network interventions that are responsive to individuals' needs among ...
ID/HIV Physician Ambassadors: Advancing Policy to Improve ...This article discusses the advocacy of ID/HIV physicians and other healthcare professionals in federal health policy.
HIV Prevention Ambassador Training Package• Helping Ambassadors to develop their own support networks. • Facilitating community engagement activities with community leaders, health care providers ...
8.clinicaltrials.ucsd.educlinicaltrials.ucsd.edu/hiv-aids
UCSD HIV/AIDS Clinical Trials for 2025 — San DiegoPrevention Ambassadors: Intervention to Promote HIV Service Engagement in the Networks of SSP Clients. open to eligible people ages 18 years ...
An Enhanced Social Network Strategy to Increase the Uptake ...Social network approaches have led to increased HIV testing uptake. Social network interventions that are responsive to individuals' needs among ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security